Patients are referred from around the world to the UCLA Stroke Center and receive comprehensive evaluation by a team of specialists that includes stroke neurologists, vascular neurosurgeons, interventional neuroradiologists, emergency physicians, and rehabilitation physicians. Patient services are coordinated through the Neurovascular Clinic, the Stroke Prevention Clinic, and the Cerebral Blood Flow Laboratory. The Stroke Center's programs include the following:

• CEREBRAL BLOOD FLOW -- Detection of ischemia and vasospasm by transcranial Doppler ultrasound, TCD embolus detection, and xenon blood flow in OR, ICU, and endovascular procedure suite.
  
  
• ELECTROPHYSIOLOGY -- For continuous monitoring during embolization, neurosurgery, and intensive care.
  
  
• INTERVENTIONAL NEUROVASCULAR SURGERY -- For embolization of complex intracranial and spinal vascular malformations and tumors, cerebral angioplasty, and intra-arterial thrombolysis.
  

  View stroke success stories from the interventional Neurovascular Surgery

  
  
• NEUROIMAGING -- For defining anatomy and physiology of cerebrovascular disorders by MR (diffusion, perfusion, spectroscopy, angiography), xenon-CT, 3-D CT angiography, PET, and super-selective angiography.
  
  
• NEUROVASCULAR SURGERY -- For cerebral arterial bypass procedures, carotid endarterctomy, and surgical treatment of aneurysms and vascular malformations.
  
• STEREOTACTIC RADIOSURGERY -- For small inoperable AVMs or in combination with embolization and surgery for large AVMs.
  
  
• STROKE IN THE YOUNG -- UCLA's Young Stroke Clinic offers comprehensive assessment and treatment for individuals under age 45 with stroke/TIA.
  
  
• STROKE PREVENTION -- State-of-the-art evaluation and intervention for individuals of any age at increased risk for ischemic and hemorrhagic stroke.
  
  
• LOS ANGELES PARAMEDIC STROKE SCREEN (LAPSS) -- A new three-minute screening test that detects one-sided motor paralysis allows paramedics and other first-responders to rapidly identify people experiencing a stroke, and may soon enable on-the-scene treatment with drugs that can limit the potentially extensive damage caused by these "brain attacks." The screening test, developed at UCLA, can shorten the time to actual treatment by an average of 90 minutes.